ESC Premium Access

Is rivaroxaban associated with shorter hospital stays and reduced costs vs. parenteral bridging to warfarin among pulmonary embolism patients?

Congress Presentation

About the speaker

Doctor Erin Weeda

University of Connecticut, Storrs (United States of America)
0 follower

4 more presentations in this session

State of the art in the management of pulmonary embolism.

Speaker: Doctor C. Becattini (Perugia, IT)


Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation

Speaker: Doctor E. Klok (Leiden, NL)


National trends in inferior vena cava filter placement in the United States from 2005 to 2013

Speaker: Professor D. Brown (St Louis, US)


Future direction for research in pulmonary embolism.

Speaker: Professor H. Buller (Amsterdam, NL)


Access the full session

Optimizing the treatment of pulmonary embolism

Speakers: Doctor E. Weeda, Doctor C. Becattini, Doctor E. Klok, Professor D. Brown, Professor H. Buller

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb